A new drug, Aducanumab, is in early stages of development. It shows great promise to reduce the characteristic protein plaques that can be found in the brains of Alzheimer patients. In a study that needs to be backed up by a bigger study it has been found that the new drug is safe and may halt memory decline.
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.
